Wegovy (Semaglutide) in Thailand
A practical guide to semaglutide for chronic weight management, including medical eligibility, weekly dose escalation, common side effects and treatment follow-up in Thailand.
Wegovy is a prescription medicine. Treatment is not guaranteed and suitability must be assessed by a licensed physician.
What is Wegovy?
Wegovy is a prescription semaglutide treatment used together with a reduced-calorie diet and increased physical activity for weight management in eligible patients.
Although Wegovy and Ozempic contain the same active ingredient, they are different branded products with different approved uses, pen presentations and dose schedules. They should not be treated as interchangeable.
What ThailandSlim does
- Provides educational treatment information
- Routes new patients to medical consultation
- Offers a review path for previous users
- Supports physician-led treatment decisions
How semaglutide may support weight management
Semaglutide acts on the GLP-1 receptor and influences appetite-related signalling, fullness, food intake and digestion.
Appetite signalling
It may reduce hunger and food cravings in some patients.
Fullness
It can increase feelings of fullness and support reduced calorie intake.
Digestion
It may slow gastric emptying, especially after treatment begins, which can also contribute to gastrointestinal side effects.
Wegovy dosage chart
Wegovy is generally increased gradually over 16 weeks to reduce gastrointestinal side effects. The schedule below is an educational overview, not a personal dosing plan.
Who may be considered?
Eligibility depends on body mass index, weight-related health conditions, medical history, current medicines, previous weight-management attempts and individual risk factors.
Adults with obesity
Wegovy may be considered for adults whose BMI meets the applicable obesity threshold.
Adults with overweight
Some adults with overweight and at least one weight-related health condition may also meet treatment criteria.
Already using treatment
A review should include the exact product, current dose, last injection, response and side-effect history.
What the doctor may ask
- Current weight, height, BMI and treatment goals
- Weight-related health conditions
- Previous semaglutide or other GLP-1 treatment
- Current prescription and non-prescription medicines
- Kidney, pancreas, gallbladder or gastrointestinal history
- Diabetes, glucose-lowering medicines and eye complications
- Pregnancy, breastfeeding or plans for pregnancy
Common and serious side effects
| Common effects | Contact a clinician | Seek urgent care |
|---|---|---|
| Nausea, diarrhoea, vomiting, constipation, abdominal pain, headache, tiredness, indigestion or bloating. | Persistent vomiting, inability to drink, dehydration, severe constipation, worsening vision or symptoms that do not improve. | Severe and persistent abdominal pain, signs of a serious allergic reaction, fainting, chest pain or another urgent medical concern. |
Wegovy vs Ozempic
Both treatments contain semaglutide, but they are designed and authorised for different primary purposes.
| Feature | Wegovy | Ozempic |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| General approved purpose | Chronic weight management for eligible patients | Type 2 diabetes treatment |
| Typical starting dose | 0.25 mg once weekly | 0.25 mg once weekly |
| Typical dose pathway | 0.25 → 0.5 → 1 → 1.7 → 2.4 mg | 0.25 → 0.5 → 1 mg, with 2 mg available in some markets |
| Interchangeable? | No. Do not switch brands or copy one product’s dosing schedule to the other without medical guidance. | |
How the ThailandSlim process works
Choose the correct path
New patients start with consultation. Previous users start with treatment review.
Submit information
Provide your medical history, medicines, previous treatment and goals.
Medical review
A physician assesses suitability and may request laboratory results or additional information.
Receive the next step
If treatment may be appropriate, the team explains the plan, dose escalation, monitoring and follow-up.
Treatment works best with follow-up
Medication should be combined with sustainable nutrition, movement, hydration, sleep and ongoing medical monitoring.
- Use the same scheduled day each week unless instructed otherwise
- Follow storage and injection instructions exactly
- Stay hydrated, especially during gastrointestinal side effects
- Eat smaller meals when nausea is present
- Attend follow-up and report side effects
Compare your options
Ready to take the next step?
Choose the correct path based on whether you are new to treatment or already using Wegovy or another weight-management medicine.
Frequently asked questions
Is Wegovy the same as semaglutide?
Wegovy is a brand name for a semaglutide treatment. Other semaglutide products can have different approved uses, pen strengths and dosing schedules.
Is Wegovy the same as Ozempic?
No. Both contain semaglutide, but Wegovy is designed for chronic weight management while Ozempic is primarily used for type 2 diabetes. They should not be considered interchangeable.
Can I start directly at 2.4 mg?
No. Wegovy is normally increased gradually over 16 weeks. Starting at a high dose can substantially increase the risk of gastrointestinal side effects.
Can I switch directly from Ozempic or Mounjaro?
Do not switch products or doses without medical review. The medicine, current dose, last injection date, treatment response and side effects all matter.
What if I miss a dose?
Follow the instructions supplied with the exact Wegovy product and contact a clinician or pharmacist when uncertain. Do not double the dose without guidance.
Are results guaranteed?
No. Appetite, weight and side-effect responses vary between individuals, and long-term results also depend on follow-up and sustainable lifestyle changes.
Information basis: Current regulatory product information should be consulted before treatment. Product approvals, pen presentations and instructions may vary by country.